At longer follow-up through week 104, greater waist circumference reduction and, to a lesser extent, a modest trend toward lower MACE with greater weight loss in the semaglutide group were associated with lower in-trial MACE incidence, whereas no consistent linear relationship was observed in the placebo group
Semaglutide works by mimicking a substance called glucagon-like peptide-1 (GLP-1) in the body
Knowing that half of US adults qualify says nothing about how many will start the drug, stay on it, and have it covered
The Blend Institute uses several different types of IV protocols targeting specific problems
During your consultation, your provider will consider all aspects of your health, preferences, and insurance to recommend the best path forward